With a rich background in venture capital, the fund manager has successfully executed over 50 deals across technology and healthcare sectors, primarily in North America and Europe. Their strategic, operator-first approach has led to several notable exits, including a prominent biotech firm. Deeply committed to thematic investments, they focus on identifying disruptive innovations at the early and growth stages. This blend of hands-on experience and keen market insight positions them as a leading figure in the venture landscape.